PHAR LLC, a United States-based boutique health care consultancy that practices health economics and outcomes research, has named Mallik Greene, BPharm, PhD, DBA as its new vice president for Health Economics and Outcomes Research, it was reported yesterday.

Dr Greene has worked in the pharmaceutical industry for nearly two decades. Working at such globally recognised pharmaceutical companies as Eli Lilly, Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, Otsuka, and Vertex Pharmaceuticals. Dr Greene developed and implemented successful strategies to improve brand differentiation and demonstrate value to payers, physicians and patients. His work has resulted in more than 200 peer-reviewed publications in dozens of journals and conferences, spanning a wide variety of therapeutic areas.

Dr Greene's experience and training include a degree in pharmacy, a PhD in health economics and outcomes research, post-doctoral fellowship in health economics and outcomes research and a doctorate in business administration.